SAGE-547
Showing 26 - 50 of 110
MDD, Insomnia Trial in United States (SAGE-217, Placebo)
Terminated
- Major Depressive Disorder
- Insomnia
- SAGE-217
- Placebo
-
Little Rock, Arkansas
- +27 more
Oct 13, 2022
Pancreatic Ductal Adenocarcinoma Trial (JPI-547, modified FOLFIRINOX, Gemcitabine-nab-paclitaxel)
Not yet recruiting
- Pancreatic Ductal Adenocarcinoma
- JPI-547
- +2 more
- (no location specified)
Feb 16, 2022
Healthy Aging Trial in Sherbrooke (2 months of reduced carb menus)
Not yet recruiting
- Healthy Aging
- 2 months of reduced carb menus
-
Sherbrooke, Quebec, CanadaResearch Center on Aging
Aug 30, 2023
Electronic Self-Administered Gerocognitive Examination (eSAGE)
Active, not recruiting
- Mild Cognitive Impairment
- Dementia
- neuropsychological testing
- eSAGE testing
-
Columbus, OhioThe Ohio State University
Apr 28, 2022
Gastro-Intestinal Cancer Trial in New Brunswick (Four week alternating FOLFOX and FOLFIRI (sFOLFOXIRI))
Recruiting
- Gastro-Intestinal Cancer
- Four week alternating FOLFOX and FOLFIRI (sFOLFOXIRI)
-
Hamilton, New Jersey
- +6 more
Oct 24, 2022
Bipolar Disorder I, Bipolar Disorder II, Major Depressive Episode Trial in United States (SAGE-217, Placebo)
Parkinson Disease Trial in United States (SAGE-217, Levodopa, Antiparkinsonian Agent(s))
Healthy Volunteer Trial in Newark (SAGE-904, Placebo, Ketamine)
Completed
- Healthy Volunteer
- SAGE-904
- +2 more
-
Newark, New JerseySage Investigational Site
Jan 20, 2022
Postpartum Depression Trial in United States (SAGE-217 15/20 mg Oral Solution, Placebo, SAGE 217 30 mg Capsules)
Completed
- Postpartum Depression
- SAGE-217 15/20 mg Oral Solution
- +2 more
-
Little Rock, Arkansas
- +26 more
Feb 3, 2022
Brain Tumor, Brain Metastases Trial in Toronto (Dynamic susceptibility contrast magnetic resonance imaging (DSC MRI))
Recruiting
- Brain Tumor
- Brain Metastases
- Dynamic susceptibility contrast magnetic resonance imaging (DSC MRI)
-
Toronto, Ontario, CanadaUniversity Health Network
May 2, 2022
Major Depression Trial in United States (SAGE-217, Placebo)
Super-Refractory Status Epilepticus Trial (SAGE-547)
No longer available
- Super-Refractory Status Epilepticus
- SAGE-547
- (no location specified)
Nov 10, 2017
Oxidative Stress, Inflammation, Body Weight Trial in Ioannina (Hydroxytyrosol/Essential oils)
Completed
- Oxidative Stress
- +3 more
- Hydroxytyrosol/Essential oils
-
Ioannina, Epirus, GreeceUniversity of Ioannina
Jan 9, 2023